Replies to post #89163 on Regen BioPharma Inc (RGBP)

[johnny smartask]

One would think that having a couple of IND's would have been really valuable. Why do you think nothing ever came of them.

[Cooway]

What is Oncology Pharma doing with the RGBP product?

[joe botts]

Whoa wow whewo wa wow

[Skiluc]

Exactly. So to fully apply that to Regen let me help:

In the U.S., a patent gives the holder the right to exclude others from making, using, selling, offering to sell, and importing [nuclear receptor NR2F6. And mRNA cancer Vaccines.]

Folks, the good thing about early patents is they tend to be more encompassing then later down the line patents. As they say in biotech: it pays to be early!

Way to nail it Dr. Koos!